Adding fuel to the fire: The impact of stress on the ageing brain

Trends in Neurosciences

Volumn 38, Issue 1, 2015, Pages 13-25

  Prenderville, Jack A ^a   Kennedy, Paul J ^a   Dinan, Timothy G ^a,b   Cryan, John F ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Ageing; Cognition; Inflamm ageing; Microbiota gut brain axis; Stress

Indexed keywords

NEUROTRANSMITTER; NEUROTROPHIC FACTOR;

AGING; AMNESIA; ANAMNESIS; ANXIETY; BEHAVIOR CHANGE; BRAIN; BRAIN FUNCTION; CHRONIC STRESS; COGNITION; DEPRESSION; EPIGENETICS; GENETICS; HEREDITY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INTESTINE FLORA; METABOLIC CAPACITY; MICROFLORA; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; SOCIAL BEHAVIOR; ANIMAL; CHRONIC DISEASE; GASTROINTESTINAL TRACT; MENTAL STRESS; MICROBIOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

AGING; ANIMALS; BRAIN; CHRONIC DISEASE; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 84927554547     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2014.11.001     Document Type: Review

References (187)

1. Medawar P.B. An Unsolved Problem of Biology 1952, H.K. Lewis.
2. Burke S.N., Barnes C.A. Neural plasticity in the ageing brain. Nat. Rev. Neurosci. 2006, 7:30-40.
3. Lupien S.J., et al. Effects of stress throughout the lifespan on the brain, behaviour and cognition. Nat. Rev. 2009, 10:434-445.
4. McEwen B.S. Stress, adaptation, and disease. Allostasis and allostatic load. Ann. N.Y. Acad. Sci. 1998, 840:33-44.
5. Dinan T.G. Glucocorticoids and the genesis of depressive illness. A psychobiological model. Br. J. Psychiatry 1994, 164:365-371.
6. Gamallo A., et al. Stress adaptation and adrenal activity in isolated and crowded rats. Physiol. Behav. 1986, 36:217-221.
7. Herman J.P., et al. Regulatory changes in neuroendocrine stress-integrative circuitry produced by a variable stress paradigm. Neuroendocrinology 1995, 61:180-190.
8. Magarinos A.M., McEwen B.S. Stress-induced atrophy of apical dendrites of hippocampal Ca3c neurons - comparison of stressors. Neuroscience 1995, 69:83-88.
9. Popoli M., et al. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nat. Rev. Neurosci. 2012, 13:22-37.
10. Madrigal J.L., et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001, 24:420-429.
11. Shintani F., et al. Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat. J. Neurosci. 1995, 15:1961-1970.
12. Cryan J.F., Dinan T.G. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat. Rev. 2012, 13:701-712.
13. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 2007, 87:873-904.
14. Berton O., et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 2006, 311:864-868.
15. Luine V., et al. Repeated stress causes reversible impairments of spatial memory performance. Brain Res. 1994, 639:167-170.
16. Kang S., Marks N.F. Filial caregiving is associated with greater neuroendocrine dysfunction: evidence from the 2005 National Survey of Midlife in the United States. SAGE Open Med. 2014, 2. Published online January 30, 2014, http://dx.doi.org/10.1177/2050312113520152.
17. Glaser R., Kiecolt-Glaser J.K. Stress-induced immune dysfunction: implications for health. Nat. Rev. Immunol. 2005, 5:243-251.
18. Gianaros P.J., et al. Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus. Neuroimage 2007, 35:795-803.
19. Jonsdottir I., et al. Cognitive impairment in patients with stress-related exhaustion. Stress 2013, 16:181-190.
20. Heim C., Nemeroff C.B. The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 2001, 49:1023-1039.
21. Romera I., et al. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. Eur. Psychiatry 2010, 25:58-65.
22. Cusi A.M., et al. Systematic review of the neural basis of social cognition in patients with mood disorders. J. Psychiatry Neurosci. 2012, 37:154-169.
23. Collins S.M. A role for the gut microbiota in IBS. Nat. Rev. Gastroenterol. Hepatol. 2014, 11:497-505.
24. Byrnes E.M., Bridges R.S. Reproductive experience alters anxiety-like behavior in the female rat. Horm. Behav. 2006, 50:70-76.
25. Wolitzky-Taylor K.B., et al. Anxiety disorders in older adults: a comprehensive review. Depress. Anxiety 2010, 27:190-211.
26. Bryant C., et al. The prevalence of anxiety in older adults: methodological issues and a review of the literature. J. Affect. Disord. 2008, 109:233-250.
27. Volkert J., et al. The prevalence of mental disorders in older people in Western countries - a meta-analysis. Ageing Res. Rev. 2013, 12:339-353.
28. Ni Mhaolain A.M., et al. Frailty, depression, and anxiety in later life. Int. Psychogeriatr. 2012, 24:1265-1274.
29. Bromet E., et al. Cross-national epidemiology of DSM-IV major depressive episode. BMC Med. 2011, 9:90.
30. Fiske A., et al. Depression in older adults. Annu. Rev. Clin. Psychol. 2009, 5:363-389.
31. Blazer D.G. Depression in late life: review and commentary. J. Gerontol. A: Biol. Sci. Med. Sci. 2003, 58:M249-M265.
32. Alexopoulos G.S. Depression in the elderly. Lancet 2005, 365:1961-1970.
33. Palsson S.P., et al. The incidence of first-onset depression in a population followed from the age of 70 to 85. Psychol. Med. 2001, 31:1159-1168.
34. Barrientos R.M., et al. Intracisternal interleukin-1 receptor antagonist prevents postoperative cognitive decline and neuroinflammatory response in aged rats. J. Neurosci. 2012, 32:14641-14648.
35. Callaghan C.K., et al. Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457. Neuropharmacology 2012, 63:890-897.
36. Zamzow D.R., et al. An increase in the association of GluN2B containing NMDA receptors with membrane scaffolding proteins was related to memory declines during aging. J. Neurosci. 2013, 33:12300-12305.
37. Jorm A.F., Jolley D. The incidence of dementia A meta-analysis. Neurology 1998, 51:728-733.
38. Craik F.I. Memory changes in normal aging. Curr. Direct. Psychol. Sci. 1994, 3:155-158.
39. Schaie K.W. Intellectual Development in Adulthood: The Seattle Longitudinal Study 1996, Cambridge University Press.
40. File S.E., Seth P. A review of 25 years of the social interaction test. Eur. J. Pharmacol. 2003, 463:35-53.
41. Wrzus C., et al. Social network changes and life events across the life span: a meta-analysis. Psychol. Bull. 2013, 139:53-80.
42. Carstensen L.L., Hartel C.R. When I'm 64 2006, The National Academic Press.
43. Moran J.M., et al. Social-cognitive deficits in normal aging. J. Neurosci. 2012, 32:5553-5561.
44. Sapolsky R.M., et al. The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 1986, 7:284-301.
45. Holmes M.C., et al. 11 Beta-hydroxysteroid dehydrogenase type 1 expression is increased in the aged mouse hippocampus and parietal cortex and causes memory impairments. J. Neurosci. 2010, 30:6916-6920.
46. Lupien S.J., et al. The Douglas Hospital longitudinal study of normal and pathological aging: summary of findings. J. Psychiatry Neurosci. 2005, 30:328-334.
47. Belvederi Murri M., et al. HPA axis and aging in depression: systematic review and meta-analysis. Psychoneuroendocrinology 2014, 41:46-62.
48. Mantella R.C., et al. Salivary cortisol is associated with diagnosis and severity of late-life generalized anxiety disorder. Psychoneuroendocrinology 2008, 33:773-781.
49. Hek K., et al. Anxiety disorders and salivary cortisol levels in older adults: a population-based study. Psychoneuroendocrinology 2013, 38:300-305.
50. Adam E.K., et al. Day-to-day dynamics of experience-cortisol associations in a population-based sample of older adults. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17058-17063.
51. Heinrichs M., et al. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol. Psychiatry 2003, 54:1389-1398.
52. Nutt D.J. The neuropharmacology of serotonin and noradrenaline in depression. Int. Clin. Psychopharmacol. 2002, 17(Suppl. 1):S1-S12.
53. Esteban S., et al. Chronic melatonin treatment and its precursor L-tryptophan improve the monoaminergic neurotransmission and related behavior in the aged rat brain. J. Pineal Res. 2010, 48:170-177.
54. Duarte J.M., et al. Longitudinal neurochemical modifications in the aging mouse brain measured in vivo by (1)H magnetic resonance spectroscopy. Neurobiol. Aging 2014, 35:1660-1668.
55. Magnusson K.R., Cotman C.W. Age-related changes in excitatory amino acid receptors in two mouse strains. Neurobiol. Aging 1993, 14:197-206.
56. Magnusson K.R., et al. Age-related changes in the protein expression of subunits of the NMDA receptor. Mol. Brain Res. 2002, 99:40-45.
57. Zahr N.M., et al. In vivo glutamate measured with magnetic resonance spectroscopy: behavioral correlates in aging. Neurobiol. Aging 2013, 34:1265-1276.
58. Hellstrom-Lindahl E., Court J.A. Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging. Behav. Brain Res. 2000, 113:159-168.
59. Lynch M.A. Long-term potentiation and memory. Physiol. Rev. 2004, 84:87-136.
60. Sanacora G., et al. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
61. Burgdorf J., et al. GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects. Neuropsychopharmacology 2013, 38:729-742.
62. Koike H., et al. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav. Brain Res. 2011, 224:107-111.
63. Gao F., et al. Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels. Neuroimage 2013, 78:75-82.
64. Mohler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012, 62:42-53.
65. Cryan J.F., Kaupmann K. Don't worry 'B' happy!: a role for GABA(B) receptors in anxiety and depression. Trends Pharmacol. Sci. 2005, 26:36-43.
66. McQuail J.A., et al. GABAB receptor GTP-binding is decreased in the prefrontal cortex but not the hippocampus of aged rats. Neurobiol. Aging 2011, 33. Published online December 15, 2011, http://dx.doi.org/10.1016/j.neurobiolaging.2011.11.011.
67. Bartus R.T., et al. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982, 217:408-414.
68. Erraji-Benchekroun L., et al. Molecular aging in human prefrontal cortex is selective and continuous throughout adult life. Biol. Psychiatry 2005, 57:549-558.
69. Tripp A., et al. Reduced somatostatin in subgenual anterior cingulate cortex in major depression. Neurobiol. Dis. 2011, 42:116-124.
70. Koh M.T., et al. Age-associated changes in hippocampal-dependent cognition in Diversity Outbred mice. Hippocampus 2014, 24:1300-1307.
71. Soumier A., Sibille E. Opposing effects of acute versus chronic blockade of frontal cortex somatostatin-positive inhibitory neurons on behavioral emotionality in mice. Neuropsychopharmacology 2014, 39:2252-2262.
72. Kowalski C., et al. Age-related changes in cortico-releasing factor, somatostatin, neuropeptide Y, methionine enkephalin and beta-endorphin in specific rat brain areas. Brain Res. 1992, 582:38-46.
73. Redrobe J.P., et al. The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test. Neuropsychopharmacology 2002, 26:615-624.
74. Sajdyk T.J., et al. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur. J. Pharmacol. 1999, 368:143-147.
75. Raadsheer F.C., et al. Age-related increase in the total number of corticotropin-releasing hormone neurons in the human paraventricular nucleus in controls and Alzheimer's disease: comparison of the disector with an unfolding method. J. Compar. Neurol. 1994, 339:447-457.
76. Raadsheer F.C., et al. Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am. J. Psychiatry 1995, 152:1372-1376.
77. Schable S., et al. Neurokinin3-R agonism in aged rats has anxiolytic-, antidepressant-, and promnestic-like effects and stimulates ACh release in frontal cortex, amygdala and hippocampus. Eur. Neuropsychopharmacol. 2011, 21:484-494.
78. Santarelli L., et al. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:1912-1917.
79. Nyman M.J., et al. Gender and age affect NK1 receptors in the human brain - a positron emission tomography study with [18F]SPA-RQ. Int. J. Neuropsychopharmacol. 2007, 10:219-229.
80. Calabrese F., et al. Reduced neuroplasticity in aged rats: a role for the neurotrophin brain-derived neurotrophic factor. Neurobiol. Aging 2013, 34:2768-2776.
81. Webster M.J., et al. BDNF and trkB mRNA expression in the hippocampus and temporal cortex during the human lifespan. Gene Exp. Patterns 2006, 6:941-951.
82. Lommatzsch M., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol. Aging 2005, 26:115-123.
83. Shirayama Y., et al. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 2002, 22:3251-3261.
84. Sakata K., et al. Lack of promoter IV-driven BDNF transcription results in depression-like behavior. Genes Brain Behav. 2010, 9:712-721.
85. O'Callaghan R.M., et al. Long-term treadmill exposure protects against age-related neurodegenerative change in the rat hippocampus. Hippocampus 2009, 19:1019-1029.
86. Romanczyk T., et al. Alterations in trkB mRNA in the human prefrontal cortex throughout the lifespan. Eur. J. Neurosci. 2002, 15:269-280.
87. Cao L., et al. VEGF links hippocampal activity with neurogenesis, learning and memory. Nat. Genet. 2004, 36:827-835.
88. Bernal G.M., Peterson D.A. Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells. Aging Cell 2011, 10:466-482.
89. Hunsberger J.G., et al. Antidepressant actions of the exercise-regulated gene VGF. Nat. Med. 2007, 13:1476-1482.
90. Sugaya K., et al. Septo-hippocampal cholinergic and neurotrophin markers in age-induced cognitive decline. Neurobiol. Aging 1998, 19:351-361.
91. Franceschi C., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N.Y. Acad. Sci 2000, 908:244-254.
92. Bruunsgaard H., et al. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 2001, 8:131-136.
93. Murray C.A., Lynch M.A. Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 1998, 18:2974-2981.
94. Ye S.M., Johnson R.W. Increased interleukin-6 expression by microglia from brain of aged mice. J. Neuroimmunol. 1999, 93:139-148.
95. Terao A., et al. Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol. 2002, 132:99-112.
96. Lynch A.M., et al. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol. Aging 2007, 28:845-855.
97. Barrientos R.M., et al. Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behav. Brain Res. 2002, 134:291-298.
98. Rizzo S.J.S., et al. Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes. Transl. Psychiatry 2012, 2. Published online December 4, 2012, http://dx.doi.org/10.1038/tp.2012.120.
99. Rossi S., et al. Interleukin-1 beta causes anxiety by interacting with the endocannabinoid system. J. Neurosci. 2012, 32:13896-13905.
100. Dantzer R., et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9:46-57.
101. McAfoose J., Baune B.T. Evidence for a cytokine model of cognitive function. Neurosci. Biobehav. Rev. 2009, 33:355-366.
102. Maes M., et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab. Brain Dis. 2009, 24:27-53.
103. Baune B.T., et al. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology 2012, 37:1521-1530.
104. Barzilai N., et al. The critical role of metabolic pathways in aging. Diabetes 2012, 61:1315-1322.
105. Yates K.F., et al. Impact of metabolic syndrome on cognition and brain: a selected review of the literature. Arterioscler. Thromb. Vasc. Biol. 2012, 32:2060-2067.
106. Blalock E.M., et al. Aging-related gene expression in hippocampus proper compared with dentate gyrus is selectively associated with metabolic syndrome variables in rhesus monkeys. J. Neurosci. 2010, 30:6058-6071.
107. Cadenas E. Mitochondrial free radical production and cell signaling. Mol. Aspects Med. 2004, 25:17-26.
108. Harman D. Aging - a theory based on free-radical and radiation-chemistry. J. Gerontol. 1956, 11:298-300.
109. Carney J.M., et al. Reversal of age-related increase in brain protein oxidation, decrease in enzyme-activity, and loss in temporal and spatial memory by chronic administration of the spin-trapping compound N-tert-butyl-alpha-phenylnitrone. Proc. Natl. Acad. Sci. U.S.A. 1991, 88:3633-3636.
110. Mendoza-Nunez V.M., et al. Aging-related oxidative stress in healthy humans. Tohoku J. Exp. Med. 2007, 213:261-268.
111. Chalimoniuk M., Strosznajder J.B. Aging modulates nitric oxide synthesis and cGMP levels in hippocampus and cerebellum. Effects of amyloid beta peptide. Mol. Chem. Neuropathol. 1998, 35:77-95.
112. Harkin A.J., et al. Nitric oxide synthase inhibitors have antidepressant-like properties in mice 1. Acute treatments are active in the forced swim test. Eur. J. Pharmacol. 1999, 372:207-213.
113. Lee C.K., et al. Gene-expression profile of the ageing brain in mice. Nat. Genet. 2000, 25:294-297.
114. Jiang C.H., et al. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:1930-1934.
115. Guilloux J.P., et al. Molecular evidence for BDNF- and GABA-related dysfunctions in the amygdala of female subjects with major depression. Mol. Psychiatry 2012, 17:1130-1142.
116. Cattaneo A., et al. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology 2013, 38:377-385.
117. Sweatt J.D. Experience-dependent epigenetic modifications in the central nervous system. Biol. Psychiatry 2009, 65:191-197.
118. Siegmund K.D., et al. DNA methylation in the human cerebral cortex is dynamically regulated throughout the life span and involves differentiated neurons. PLoS ONE 2007, 2:e895.
119. Mehta D., et al. Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:8302-8307.
120. Nagy C., et al. Astrocytic abnormalities and global DNA methylation patterns in depression and suicide. Mol. Psychiatry 2014, Published online March 25, 2014, http://dx.doi.org/10.1038/mp.2014.21.
121. Roberts S., et al. Serotonin tranporter methylation and response to cognitive behaviour therapy in children with anxiety disorders. Transl. Psychiatry 2014, 4:e444.
122. Sudo N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J. Physiol. 2004, 558:263-275.
123. Clarke G., et al. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatry 2013, 18:666-673.
124. Gareau M.G., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60:307-317.
125. Desbonnet L., et al. Microbiota is essential for social development in the mouse. Mol. Psychiatry 2014, 19:146-148.
126. Lyte M., et al. Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol. Behav. 2006, 89:350-357.
127. Bravo J.A., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16050-16055.
128. Messaoudi M., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br. J. Nutr. 2011, 105:755-764.
129. Tillisch K., et al. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013, 144:1394-1401.
130. Claesson M.J., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:4586-4591.
131. Claesson M.J., et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012, 488:178-184.
132. Shanahan F. The gut microbiota - a clinical perspective on lessons learned. Nat. Rev. Gastroenterol. Hepatol. 2012, 9:609-614.
133. Merrett D.L., et al. Synergistic effects of age and stress in a rodent model of stroke. Behav. Brain Res. 2010, 214:55-59.
134. Tronche C., et al. Increased stress-induced intra-hippocampus corticosterone rise associated with memory impairments in middle-aged mice. Neurobiol. Learn. Mem. 2010, 93:343-351.
135. Bloss E.B., et al. Interactive effects of stress and aging on structural plasticity in the prefrontal cortex. J. Neurosci. 2010, 30:6726-6731.
136. Buchanan J.B., et al. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology 2008, 33:755-765.
137. Shoji H., Mizoguchi K. Acute and repeated stress differentially regulates behavioral, endocrine, neural parameters relevant to emotional and stress response in young and aged rats. Behav. Brain Res. 2010, 211:169-177.
138. Duerkop B.A., et al. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376.
139. Kudielka B.M., et al. Differential heart rate reactivity and recovery after psychosocial stress (TSST) in healthy children, younger adults, and elderly adults: the impact of age and gender. Int. J. Behav. Med. 2004, 11:116-121.
140. Rohleder N., et al. Age and sex steroid-related changes in glucocorticoid sensitivity of pro-inflammatory cytokine production after psychosocial stress. J. Neuroimmunol. 2002, 126:69-77.
141. Almela M., et al. Salivary alpha-amylase response to acute psychosocial stress: the impact of age. Biol. Psychol. 2011, 87:421-429.
142. Hidalgo V., et al. Acute stress impairs recall after interference in older people, but not in young people. Horm. Behav. 2014, 65:264-272.
143. Cacioppo J.T., Hawkley L.C. Perceived social isolation and cognition. Trends Cogn. Sci. 2009, 13:447-454.
144. Steptoe A., et al. Social isolation, loneliness, and all-cause mortality in older men and women. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:5797-5801.
145. Glass T.A., et al. Social engagement and depressive symptoms in late life longitudinal findings. J. Aging Health 2006, 18:604-628.
146. Tilvis R.S., et al. Predictors of cognitive decline and mortality of aged people over a 10-year period. J. Gerontol. A: Biol. Sci. Med. Sci. 2004, 59:M268-M274.
147. Cacioppo J.T., et al. Loneliness as a specific risk factor for depressive symptoms: cross-sectional and longitudinal analyses. Psychol. Aging 2006, 21:140.
148. United Nations (UN), Department of Economic and Social Affairs, Population Division World Population Ageing 1950-2050 2002, United Nations.
149. Laviola G., et al. Risk-taking behavior in adolescent mice: psychobiological determinants and early epigenetic influence. Neurosci. Biobehav. Rev. 2003, 27:19-31.
150. Flurkey K., et al. The Mouse in Aging Research 2007, Elsevier, Burlington.
151. Ennaceur A., et al. Detailed analysis of the behavior and memory performance of middle-aged male and female CD-1 mice in a 3D maze. Behav. Brain Res. 2008, 187:312-326.
152. Francia N., et al. Spatial memory deficits in middle-aged mice correlate with lower exploratory activity and a subordinate status: role of hippocampal neurotrophins. Eur. J. Neurosci. 2006, 23:711-728.
153. Menard C., et al. Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging. J. Neurosci. 2013, 33:12792-12804.
154. Harati H., et al. Lifelong environmental enrichment in rats: impact on emotional behavior, spatial memory vividness, and cholinergic neurons over the lifespan. Age 2013, 35:1027-1043.
155. Bessa J.M., et al. Age-related qualitative shift in emotional behaviour: paradoxical findings after re-exposure of rats in the elevated-plus maze. Behav. Brain Res. 2005, 162:135-142.
156. Moretti M., et al. Emotional behavior in middle-aged rats: implications for geriatric psychopathologies. Physiol. Behav. 2011, 102:115-120.
157. Darwish M., et al. Exposure to a novel stimulus reduces anxiety level in adult and aging rats. Physiol. Behav. 2001, 72:403-407.
158. Belzung C., et al. Alpha-linolenic acid deficiency modifies distractibility but not anxiety and locomotion in rats during aging. J. Nutr. 1998, 128:1537-1542.
159. Malatynska E., et al. Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: implications for modeling elderly depression. Exp. Gerontol. 2012, 47:552-564.
160. Frick K.M., et al. Reference memory, anxiety and estrous cyclicity in C57BL/6NIA mice are affected by age and sex. Neuroscience 2000, 95:293-307.
161. Perez G.I., et al. Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:5229-5234.
162. Bouet V., et al. Continuous enriched environment improves learning and memory in adult NMRI mice through theta burst-related-LTP independent mechanisms but is not efficient in advanced aged animals. Mech. Ageing Dev. 2011, 132:240-248.
163. Costa M.S., et al. Treadmill running frequency on anxiety and hippocampal adenosine receptors density in adult and middle-aged rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2012, 36:198-204.
164. Pietrelli A., et al. Aerobic exercise prevents age-dependent cognitive decline and reduces anxiety-related behaviors in middle-aged and old rats. Neuroscience 2012, 202:252-266.
165. Torras-Garcia M., et al. Decreased anxiety levels related to aging. Exp. Brain Res. 2005, 164:177-184.
166. Meier I., et al. Expression of the snoRNA host gene gas5 in the hippocampus is upregulated by age and psychogenic stress and correlates with reduced novelty-induced behavior in C57BL/6 mice. Hippocampus 2010, 20:1027-1036.
167. Naude P.J., et al. Analysis of cognition, motor performance and anxiety in young and aged tumor necrosis factor alpha receptor 1 and 2 deficient mice. Behav. Brain Res. 2014, 258:43-51.
168. Bedrosian T.A., et al. Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11686-11691.
169. Freret T., et al. Rescue of cognitive aging by long-lasting environmental enrichment exposure initiated before median lifespan. Neurobiol. Aging 2012, 33. Published online May 2012, http://dx.doi.org/10.1016/j.neurobiolaging.2011.09.028.
170. Chugh G., et al. A high-salt diet further impairs age-associated declines in cognitive, behavioral, and cardiovascular functions in male Fischer Brown Norway rats. J. Nutr. 2013, 143:1406-1413.
171. Yau J.L., et al. Chronic treatment with the antidepressant amitriptyline prevents impairments in water maze learning in aging rats. J. Neurosci. 2002, 22:1436-1442.
172. Rowe W.B., et al. Reactivity to novelty in cognitively-impaired and cognitively-unimpaired aged rats and young rats. Neuroscience 1998, 83:669-680.
173. Leite-Almeida H., et al. The impact of age on emotional and cognitive behaviours triggered by experimental neuropathy in rats. Pain 2009, 144:57-65.
174. Schulz D., et al. Despair" induced by extinction trials in the water maze: relationship with measures of anxiety in aged and adult rats. Neurobiol. Learn. Mem. 2007, 87:309-323.
175. Pego J.M., et al. Mismatch between anxiety status and morphometric parameters in the amygdala and bed nucleus of the stria terminalis. Behav. Brain Res. 2006, 173:320-325.
176. Bergado J.A., et al. Spatial and emotional memory in aged rats: a behavioral-statistical analysis. Neuroscience 2011, 172:256-269.
177. Wikinski S.I., et al. Diazepam fails to potentiate GABA-induced chloride uptake and to produce anxiolytic-like action in aged rats. Pharmacol. Biochem. Behav. 2001, 68:721-727.
178. Frye C.A., et al. 3alpha-androstanediol, but not testosterone, attenuates age-related decrements in cognitive, anxiety, and depressive behavior of male rats. Front. Aging Neurosci. 2010, 2:15.
179. Moranis A., et al. Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice. Brain Behav. Immun. 2012, 26:721-731.
180. Topic B., et al. Extinction-induced "despair" in aged and adult rats: links to neurotrophins in frontal cortex and hippocampus. Neurobiol. Learn. Mem. 2008, 90:519-526.
181. Guan X., Dluzen D.E. Age related changes of social memory/recognition in male Fischer 344 rats. Behav. Brain Res. 1994, 61:87-90.
182. Shoji H., Mizoguchi K. Aging-related changes in the effects of social isolation on social behavior in rats. Physiol. Behav. 2011, 102:58-62.
183. Salchner P., et al. Decreased social interaction in aged rats may not reflect changes in anxiety-related behaviour. Behav. Brain Res. 2004, 151:1-8.
184. Ritchie K., Lovestone S. The dementias. Lancet 2002, 360:1759-1766.
185. Sotiropoulos I., et al. Stress acts cumulatively to precipitate Alzheimer's disease-like tau pathology and cognitive deficits. J. Neurosci. 2011, 31:7840-7847.
186. Rissman R.A., et al. Corticotropin-releasing factor receptor-dependent effects of repeated stress on tau phosphorylation, solubility, and aggregation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:6277-6282.
187. Kang J.E., et al. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:10673-10678.